The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $126.38

Today's change+1.27 +1.02%
Updated December 7 4:03 PM EST. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $126.38

Today's change+1.27 +1.02%
Updated December 7 4:03 PM EST. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings crosses above 20-day moving average

Laboratory Corporation of America Holdings closed up Wednesday by (U.S.)$1.27 or 1.02% to (U.S.)$126.38 and crossing above its 20-day moving average. Over the last five days, shares have gained 0.42%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 6.57% during the last year.

Key company metrics

  • Open(U.S.) $124.63
  • Previous close(U.S.) $125.11
  • High(U.S.) $127.11
  • Low(U.S.) $123.41
  • Bid / Ask-- / --
  • YTD % change+2.22%
  • Volume905,574
  • Average volume (10-day)605,459
  • Average volume (1-month)906,629
  • Average volume (3-month)713,700
  • 52-week range(U.S.) $97.79 to (U.S.) $141.32
  • Beta0.95
  • Trailing P/E19.94×
  • P/E 1 year forward14.25×
  • Forward PEG1.39×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $6.34
Updated December 7 4:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.97%

Based on its net profit margin of 6.97%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.74%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue2,4152,4312,3682,301
Total other revenue--------
Total revenue2,4152,4312,3682,301
Gross profit788827777741
Total cost of revenue1,6261,6041,5911,560
Total operating expense2,0912,0642,0662,057
Selling / general / administrative401408412405
Research & development--------
Depreciation / amortization41454438
Interest expense (income), net operating--------
Unusual expense (income)2371954
Other operating expenses, total--------
Operating income324367302243
Interest income (expense), net non-operating-58-54-55-57
Gain (loss) on sale of assets--------
Other--------
Income before tax263313256186
Income after tax180199161115
Income tax, total841159672
Net income180198160114
Total adjustments to net income--------
Net income before extra. items180198160114
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items180198160114
Inc. avail. to common incl. extra. items180198160114
Diluted net income180198160114
Dilution adjustment----0--
Diluted weighted average shares105104104103
Diluted EPS excluding extraordinary itemsvalue per share1.711.911.551.11
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.861.951.661.43